Raphaël Ortiz

Corporate Officer/Principal at TELIX PHARMACEUTICALS LIMITED

50 year

Consumer Services

Health Technology

Profile

Raphaël Ortiz is currently the Chief Executive Officer-Telix International at Telix Pharmaceuticals Ltd. He is also a Co-Managing Director at Rhine Pharma GmbH.
Previously, he worked as the Head-Asia Pacific Cluster at Advanced Accelerator Applications SA. Mr. Ortiz holds a graduate degree from the University of Seville and the University of Reims Champagne-Ardenne.
He also has an MBA from Kenan-Flagler Business School.

Raphaël Ortiz active positions

Companies	Position	Start
TELIX PHARMACEUTICALS LIMITED	Corporate Officer/Principal	2021-12-31

All active positions of Raphaël Ortiz

Former positions of Raphaël Ortiz

Companies	Position	End
ADVANCED ACCELERATOR APPLICATION SA(ADR)	Corporate Officer/Principal	-

See the detail of Raphaël Ortiz's experience

Training of Raphaël Ortiz

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Raphaël Ortiz's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	5
University of Seville University of Seville Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of Reims Champagne-Ardenne University of Reims Champagne-Ardenne Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Advanced Accelerator Applications SA Advanced Accelerator Applications SA Pharmaceuticals: MajorHealth Technology Develops and produces nuclear medicine and radioligand therapies	Health Technology
Kenan-Flagler Business School Kenan-Flagler Business School Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Telix Pharmaceuticals Ltd. Telix Pharmaceuticals Ltd. BiotechnologyHealth Technology Operates as a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals	Health Technology